-
公开(公告)号:US10730889B2
公开(公告)日:2020-08-04
申请号:US15936086
申请日:2018-03-26
申请人: Forma TM, LLC , Genentech, Inc.
发明人: Kenneth W. Bair , Timm R. Baumeister , Peter Dragovich , Xiongcai Liu , Snahel Patel , Po-Wai Yuen , Mark Zak , Guiling Zhao , Yamin Zhang , Xiaozhang Zheng
IPC分类号: C07D519/00 , C07D471/04 , C07D487/04 , C07D491/048 , C07D495/04 , A61K31/438 , A61K31/496 , A61K31/497 , A61K31/501 , A61K31/519 , A61K31/5377 , A61K31/541 , A61K45/06 , A61K31/444 , A61K31/4545 , A61K31/506 , A61K31/513
摘要: Provided are amido spirocyclic amide and sulfonamide compounds, pharmaceutical compositions comprising such compounds, and methods of treatment using such compounds.
-
公开(公告)号:US09822129B2
公开(公告)日:2017-11-21
申请号:US14382210
申请日:2013-03-01
申请人: GENENTECH,INC. , FORMA TM, LLC , Po-Wai Yuen
发明人: Kenneth W Bair , Timm R Baumeister , Peter Dragovich , Xiongcai Liu , Snahel Patel , Po-Wai Yuen , Mark Zak , Guiling Zhao , Yamin Zhang , Xiaozhang Zheng
IPC分类号: C07D519/00 , C07D471/04 , C07D487/04 , C07D491/048 , C07D495/04 , A61K31/438 , A61K31/496 , A61K31/497 , A61K31/501 , A61K31/519 , A61K31/5377 , A61K31/541 , A61K45/06
CPC分类号: C07D519/00 , A61K31/438 , A61K31/444 , A61K31/4545 , A61K31/496 , A61K31/497 , A61K31/501 , A61K31/506 , A61K31/513 , A61K31/519 , A61K31/5377 , A61K31/541 , A61K45/06 , C07D471/04 , C07D487/04 , C07D491/048 , C07D495/04
摘要: Provided are amido spirocyclic amide and sulfonamide compounds, pharmaceutical compositions comprising such compounds, and methods of treatment using such compounds.
-
公开(公告)号:US20180339998A1
公开(公告)日:2018-11-29
申请号:US15936086
申请日:2018-03-26
申请人: Forma TM, LLC , Genentech, Inc.
发明人: Kenneth W. Bair , Timm R. Baumeister , Peter Dragovich , Xiongcai Liu , Snahel Patel , Po-Wai Yuen , Mark Zak , Guiling Zhao , Yamin Zhang , Xiaozhang Zheng
IPC分类号: C07D519/00 , A61K45/06 , C07D471/04 , A61K31/519 , A61K31/5377 , A61K31/541 , A61K31/496 , A61K31/497 , A61K31/513 , A61K31/444 , A61K31/4545 , A61K31/506 , A61K31/438 , C07D495/04 , C07D491/048 , C07D487/04 , A61K31/501
摘要: Provided are amido spirocyclic amide and sulfonamide compounds, pharmaceutical compositions comprising such compounds, and methods of treatment using such compounds.
-
公开(公告)号:US11129832B2
公开(公告)日:2021-09-28
申请号:US16666273
申请日:2019-10-28
申请人: Genentech, Inc.
发明人: Anthony Estrada , Liting Dong , Kevin X. Chen , Paul Gibbons , Malcolm Huestis , Terry Kellar , Wen Liu , Changyou Ma , Joseph P. Lyssikatos , Alan G. Olivero , Snahel Patel , Daniel Shore , Michael Siu
IPC分类号: C07D471/08 , A61K31/506 , A61K45/06 , A61K31/5386 , A61K31/4545 , A61K31/5377 , A61K31/55 , A61K35/30 , C07D401/14 , C07D403/04 , C07D403/14 , C07D405/14 , C07D413/14 , C07D471/18 , C07D487/08 , C07D491/08 , C07D495/08 , C07D519/00 , A61K31/553 , C07D417/14 , C07D487/14 , C07D487/18 , A61K31/444
摘要: The present invention provides for compounds of Formula I-I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R1, R2, R3, X1, X2, A and Cy variable in Formula I-I all have the meaning as defined herein.
-
公开(公告)号:USRE47848E1
公开(公告)日:2020-02-11
申请号:US15902746
申请日:2018-02-22
申请人: Genentech, Inc.
发明人: Anthony Estrada , Alan G. Olivero , Snahel Patel , Michael Siu , Joseph Lyssikatos , Malcolm Huestis , Terry Kellar
IPC分类号: A61K31/55 , C07D403/14 , A61K35/30 , C07D491/08 , C07D495/08 , C07D519/00 , C07D471/08 , A61K45/06 , A61K31/5386 , C07D487/08 , C07D413/14 , C07D471/18 , C07D405/14 , C07D403/04 , C07D401/14 , A61K31/5377 , A61K31/506 , A61K31/4545 , A61K31/444 , A61K31/553 , A61K31/155
摘要: The present invention provides for compounds of Formula I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R1, R2, R3, X1, X2, A and Cy variable in Formula all have the meaning as defined herein.
-
公开(公告)号:US10028942B2
公开(公告)日:2018-07-24
申请号:US15374047
申请日:2016-12-09
申请人: Genentech, Inc.
发明人: Anthony Estrada , Wen Liu , Snahel Patel , Michael Siu
IPC分类号: A61K31/4439 , A61K31/437 , A61K31/4545
摘要: The present invention provides for compounds of Formula (I) and various embodiments thereof, and compositions comprising compounds of Formula (I) and various embodiments thereof. In compounds of Formula I, the groups R1, R2, R3, R4, R5, R6 and R7 have the meaning as described herein. The present invention also provides for methods of using compounds of Formula I and compositions comprising compounds of Formula (I) as DLK inhibitors and for treating neurodegeneration diseases and disorders.
-
公开(公告)号:US20180133219A1
公开(公告)日:2018-05-17
申请号:US15868301
申请日:2018-01-11
申请人: Genentech, Inc.
发明人: Anthony Estrada , Liting Dong , Kevin X. Chen , Paul Gibbons , Malcolm Huestis , Terry Kellar , Wen Liu , Changyou Ma , Joseph Lyssikatos , Alan Olivero , Snahel Patel , Daniel Shore , Michael Siu
IPC分类号: A61K31/506 , A61K31/444 , A61K35/30 , C07D487/14 , A61K31/553 , C07D417/14 , C07D487/18 , A61K31/55 , C07D401/14 , A61K31/5377 , C07D495/08 , A61K31/4545 , C07D519/00 , A61K31/5386 , A61K45/06 , C07D471/08 , C07D403/04 , C07D403/14 , C07D405/14 , C07D413/14 , C07D471/18 , C07D487/08 , C07D491/08
CPC分类号: A61K31/506 , A61K31/444 , A61K31/4545 , A61K31/5377 , A61K31/5386 , A61K31/55 , A61K31/553 , A61K35/30 , A61K45/06 , C07D401/14 , C07D403/04 , C07D403/14 , C07D405/14 , C07D413/14 , C07D417/14 , C07D471/08 , C07D471/18 , C07D487/08 , C07D487/14 , C07D487/18 , C07D491/08 , C07D495/08 , C07D519/00 , A61K2300/00
摘要: The present invention provides for compounds of Formula I-I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R1, R2, R3, X1, X2, A and Cy variable in Formula I-I all have the meaning as defined herein.
-
公开(公告)号:US09868720B2
公开(公告)日:2018-01-16
申请号:US14928034
申请日:2015-10-30
申请人: Genentech, Inc.
发明人: Frederick Cohen , Snahel Patel
IPC分类号: A61K31/506 , C07D401/14 , C07D405/14 , C07D403/14 , C07D471/04 , C07D493/08 , A61K31/5377 , A61K31/5386 , A61K31/553 , A61K35/30 , C07D409/14 , C07D413/14 , C07D487/04 , C07D491/08 , C07D491/107 , C07D498/08
CPC分类号: C07D401/14 , A61K31/506 , A61K31/5377 , A61K31/5386 , A61K31/553 , A61K35/30 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D471/04 , C07D487/04 , C07D491/08 , C07D491/107 , C07D493/08 , C07D498/08
摘要: The present invention provides for pyrimidine compounds of Formula I-I and embodiments thereof In Formula I-I in which R1, R2, R3, R4, R5, R6, m, n and the “het” ring are as described herein. Also provided are pharmaceutical compositions comprising compounds of Formula I and methods of using such compounds and compositions.
-
公开(公告)号:US09266862B2
公开(公告)日:2016-02-23
申请号:US14267011
申请日:2014-05-01
申请人: Genentech, Inc.
发明人: Anthony Estrada , Alan G. Olivero , Snahel Patel , Michael Siu
IPC分类号: C07D403/14 , A61K31/4545 , A61K31/506 , A61K31/5377 , A61K31/55 , A61K35/30 , C07D401/14 , C07D403/04 , C07D405/14 , C07D413/14 , C07D471/18 , C07D487/08 , C07D491/08 , C07D495/08 , C07D519/00 , C07D471/08 , A61K45/06 , A61K31/5386
CPC分类号: A61K31/506 , A61K31/444 , A61K31/4545 , A61K31/5377 , A61K31/5386 , A61K31/55 , A61K31/553 , A61K35/30 , A61K45/06 , C07D401/14 , C07D403/04 , C07D403/14 , C07D405/14 , C07D413/14 , C07D417/14 , C07D471/08 , C07D471/18 , C07D487/08 , C07D487/14 , C07D487/18 , C07D491/08 , C07D495/08 , C07D519/00 , A61K2300/00
摘要: The present invention provides for compounds of Formula I and embodiments and salts thereof for the treatment of diseases (e.g., neurodegenerative diseases). R1, R2, R3, X1, X2, A and Cy variable in Formula all have the meaning as defined herein.
摘要翻译: 本发明提供式I化合物及其实施方案及其盐用于治疗疾病(如神经变性疾病)。 式中的R 1,R 2,R 3,X 1,X 2,A和Cy变量均具有如本文所定义的含义。
-
公开(公告)号:US11834461B2
公开(公告)日:2023-12-05
申请号:US17147449
申请日:2021-01-12
申请人: Genentech, Inc.
发明人: Snahel Patel , Gregory Hamilton , Guiling Zhao , Huifen Chen , Blake Daniels , Craig Stivala
IPC分类号: C07D498/04 , C07D487/04 , A61P25/16 , A61P25/28 , A61P17/06 , A61P21/00 , A61P19/02 , A61P1/00 , C07D235/12 , C07D471/04
CPC分类号: C07D498/04 , A61P25/16 , A61P25/28 , C07D235/12 , C07D471/04 , C07D487/04 , A61P1/00 , A61P17/06 , A61P19/02 , A61P21/00
摘要: The invention provides novel compounds having the general formula I:
wherein R1, the A ring and the B ring are as described herein, pharmaceutical compositions including the compounds, and methods of using the compounds.
-
-
-
-
-
-
-
-
-